Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
158 Results for "
bone resorption
" in MedChemExpress (MCE) Product Catalog:
Products (158)
158 Results for "bone resorption" in MCE Product Catalog:
Target:
Neridronate is a bisphosphonate. Bisphosphonates initiate the Apoptotic process. Neridronate sodium reduces the levels of bone resorption, bone turnover markers, the degree of back pain, and the risk of fractures. Neridronate inhibits capillary tube formation. Neridronate itself has weak anticancer activity, but liposomal encapsulation enhances this activity. Neridronate can be used in research related to demineralizing metabolic bone diseases, thalassemia-associated osteoporosis, chronic inflammatory diseases, cancer, and osteogenesis imperfecta .
Cat. No.: HY-P0322
CAS No.: 111119-28-9
Synonyms: EMD 56574
Target:
Research Areas:
Synonyms: L-235
Target:
Research Areas:
L-006235 (L-235) is a potent, selective, reversible and orally active inhibitor of cathepsin K, with an IC50 of 5 nM in bone resorption assay. L-006235 shows selectivity for cathepsin K (Ki=0.2 nM) over cathepsin B, cathepsin L, and cathepsin S (Ki=1, 6, and 47 μM, respectively). L-006235 can reduce collagen degradation and prevent bone loss .
Synonyms: SB-462795
Target:
Research Areas:
Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V with Ki values of 41 pM, 68 pM, and 53 pM, respectively. Relacatib inhibits endogenous cathepsin K in situ in human osteoclasts and human osteoclast-mediated bone resorption with IC50 values of 45 nM and 70 nM, respectively. Relacatib inhibits bone resorption in vitro in human tissue as well as in cynomolgus monkeys in vivo .
Synonyms: CID23612552
ML191 (CID23612552) is a GPR55 antagonist. ML191 inhibits ERK phosphorylation and PKC β II translocation downstream of GPR55 signaling. ML191 suppresses LPI-induced activation of ERK1/2 and p38 MAPK signaling, blocks the transcription of RANKL-induced osteoclastogenesis markers, and reduces the bone resorption activity of mature osteoclasts promoted by RANKL. ML191 can be used to investigate diseases associated with bone degradation caused by excessive osteoclast activation, such as osteoporosis and bone damage during the formation stage of bone metastases .
Cat. No.: HY-W145486
CAS No.: 299-28-5
Cat. No.: HY-N9331
CAS No.: 163046-73-9
Synonyms: Cimicidanol-3-O-β-d-xyloside
Category:
Triterpenes Terpenoids Metabolic Disease Plants Cimicifuga foetida Linn. Disease Research Fields Ranunculaceae Extract
Target:
Cat. No.: HY-N10117
CAS No.: 138250-72-3
Category:
Alkaloids Hordeum vulgare var. coeleste Linnaeus Other Diseases Plants Gramineae Extract Disease Research Fields Indole Alkaloids
Target:
Target:
Research Areas:
SC-19220 is a prostaglandin E2 receptor EP1 antagonist. SC-19220 blocks functional EP1 receptor activation, and RANK/RANKL signaling pathway. SC-19220 inhibits osteoclast formation and bone resorption by pre-existing osteoclasts. SC-19220 can be used for the research of osteoporotic disorders, inflammatory bone resorption .
Cat. No.: HY-N7646
CAS No.: 143601-09-6
Category:
Curculigo orchioides Gaertn. Other Diseases Amaryllidaceae Extract Phenols Polyphenols Plants Disease Research Fields
Target:
Cat. No.: HY-123370
CAS No.: 174185-16-1
Target:
Research Areas:
FR-167356 is a potent, orally active and selective vacuolar ATPase inhibitor with IC50 values of 170, 220, 370, and 1200 nM for osteoclast plasma membranes, macrophage microsomes, renal brush border membranes, and liver lysosomal membranes, respectively. FR-167356 inhibits bone resorption and ovariectomy-induced bone loss .
Target:
Research Areas:
Incadronic acid inhibits growth of Dictyostelium discoideum with an IC50 of 1.6 μM. Incadronic acid binds the farnesyl diphosphate synthase (FPPS) in Leishmania major with the Ki of 23 nM. Incadronic acid inhibits the bone resorption and reduces bone loss, that can be used in osteoporosis research. Incadronic acid inhibits the proliferation of cells RAW264.7, PC-3 and MCF-7 with IC50 of 48 to 228.6 µM .
Cat. No.: HY-P1418A
Target:
Research Areas:
Cat. No.: HY-N5023
CAS No.: 19950-55-1
Category:
Lignans Metabolic Disease Magnolia Liliflora Desr. Phenylpropanoids Plants Magnoliaceae Extract Disease Research Fields
Target:
Cat. No.: HY-P0284
CAS No.: 162929-64-8
Target:
Research Areas:
Cat. No.: HY-P0284A
Target:
Research Areas:
Cat. No.: HY-P1288
CAS No.: 122613-29-0
Synonyms: PKC fragment (530-558)
Cat. No.: HY-P4798
CAS No.: 155918-12-0
Synonyms: Human PTHrP(107-111) amide
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
